Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

19 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Potency and spectrum of tigecycline tested against an international collection of bacterial pathogens associated with skin and soft tissue infections (2000-2004).
Fritsche TR, Sader HS, Stilwell MG, Dowzicky MJ, Jones RN. Fritsche TR, et al. Among authors: stilwell mg. Diagn Microbiol Infect Dis. 2005 Jul;52(3):195-201. doi: 10.1016/j.diagmicrobio.2005.05.003. Diagn Microbiol Infect Dis. 2005. PMID: 16105564
Interim susceptibility testing for ceftaroline, a new MRSA-active cephalosporin: selecting potent surrogate β-lactam markers to predict ceftaroline activity against clinically indicated species.
Jones RN, Flamm RK, Sader HS, Stilwell MG. Jones RN, et al. Among authors: stilwell mg. Diagn Microbiol Infect Dis. 2013 Jan;75(1):89-93. doi: 10.1016/j.diagmicrobio.2012.08.022. Epub 2012 Sep 28. Diagn Microbiol Infect Dis. 2013. PMID: 23023107
Ceftaroline activity tested against uncommonly isolated Gram-positive pathogens: report from the SENTRY Antimicrobial Surveillance Program (2008-2011).
Sader HS, Jones RN, Stilwell MG, Flamm RK. Sader HS, et al. Among authors: stilwell mg. Int J Antimicrob Agents. 2014 Mar;43(3):284-6. doi: 10.1016/j.ijantimicag.2013.10.004. Epub 2013 Nov 5. Int J Antimicrob Agents. 2014. PMID: 24342717
Contemporary potencies of minocycline and tetracycline HCL tested against Gram-positive pathogens: SENTRY Program results using CLSI and EUCAST breakpoint criteria.
Jones RN, Wilson ML, Weinstein MP, Stilwell MG, Mendes RE. Jones RN, et al. Among authors: stilwell mg. Diagn Microbiol Infect Dis. 2013 Apr;75(4):402-5. doi: 10.1016/j.diagmicrobio.2013.01.022. Diagn Microbiol Infect Dis. 2013. PMID: 23514756
Contemporary tetracycline susceptibility testing: doxycycline MIC methods and interpretive criteria (CLSI and EUCAST) performance when testing Gram-positive pathogens.
Jones RN, Stilwell MG, Wilson ML, Mendes RE. Jones RN, et al. Among authors: stilwell mg. Diagn Microbiol Infect Dis. 2013 May;76(1):69-72. doi: 10.1016/j.diagmicrobio.2013.01.023. Epub 2013 Mar 13. Diagn Microbiol Infect Dis. 2013. PMID: 23490012
Comprehensive update of dalbavancin activity when tested against uncommonly isolated streptococci, Corynebacterium spp., Listeria monocytogenes, and Micrococcus spp. (1357 strains).
Jones RN, Stilwell MG. Jones RN, et al. Among authors: stilwell mg. Diagn Microbiol Infect Dis. 2013 Jun;76(2):239-40. doi: 10.1016/j.diagmicrobio.2013.01.002. Epub 2013 Feb 13. Diagn Microbiol Infect Dis. 2013. PMID: 23414746
Antipseudomonal activity of piperacillin/tazobactam: more than a decade of experience from the SENTRY Antimicrobial Surveillance Program (1997-2007).
Jones RN, Stilwell MG, Rhomberg PR, Sader HS. Jones RN, et al. Among authors: stilwell mg. Diagn Microbiol Infect Dis. 2009 Nov;65(3):331-4. doi: 10.1016/j.diagmicrobio.2009.06.022. Diagn Microbiol Infect Dis. 2009. PMID: 19822273
In vitro potency of doripenem tested against an international collection of rarely isolated bacterial pathogens.
Jones RN, Bell JM, Sader HS, Turnidge JD, Stilwell MG. Jones RN, et al. Among authors: stilwell mg. Diagn Microbiol Infect Dis. 2009 Apr;63(4):434-9. doi: 10.1016/j.diagmicrobio.2009.01.025. Diagn Microbiol Infect Dis. 2009. PMID: 19302927
Garenoxacin activity against isolates form patients hospitalized with community-acquired pneumonia and multidrug-resistant Streptococcus pneumoniae.
Jones RN, Sader HS, Stilwell MG, Fritsche TR. Jones RN, et al. Among authors: stilwell mg. Diagn Microbiol Infect Dis. 2007 May;58(1):1-7. doi: 10.1016/j.diagmicrobio.2007.01.019. Epub 2007 Apr 3. Diagn Microbiol Infect Dis. 2007. PMID: 17408904
Activity of garenoxacin, an investigational des-F(6)-quinolone, tested against pathogens from community-acquired respiratory tract infections, including those with elevated or resistant-level fluoroquinolone MIC values.
Jones RN, Fritsche TR, Sader HS, Stilwell MG. Jones RN, et al. Among authors: stilwell mg. Diagn Microbiol Infect Dis. 2007 May;58(1):9-17. doi: 10.1016/j.diagmicrobio.2007.01.020. Epub 2007 Apr 3. Diagn Microbiol Infect Dis. 2007. PMID: 17408903
19 results
Jump to page
Feedback